White Paper
Demanding More from AI Governance in Drug Safety
Discover how AI governance is transforming drug safety. Learn to implement generative AI in pharmacovigilance while ensuring compliance and patient trust.
Jul 25, 2025
Download

Explore how pharmaceutical companies can responsibly implement AI in drug safety amid evolving global regulations. This white paper, authored by Marie Flanagan, Regulatory and AI Governance Lead at IQVIA, outlines the current regulatory landscape, key challenges in adopting generative AI, and the critical role of AI governance in ensuring transparency, compliance, and patient safety.

Learn how to build trust in AI systems, select the right technology partners, and future-proof your pharmacovigilance operations through proactive governance strategies.

Related solutions

Contact Us